Thomas W. Elrod

• Name BioAge Labs, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ:BIOA). The investigation concerns whether BioAge and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Enphase Energy, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Enphase Energy, Inc. (“Enphase” or the “Company”) (NASDAQ:ENPH) securities during the period from April 25, 2023, through October 22, 2024, (“the Class Period”). Investors have until February 11, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name MGP Ingredients, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired MGP Ingredients, Inc. (“MGP Ingredients” or the “Company”) (NASDAQ: MGPI) securities during the period from May 4, 2023 to October 30, 2024 (“the Class Period”). Investors have until February 14, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.  

• Name Sun Communities, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Eastern Michigan on behalf of those who acquired Sun Communities, Inc. (“SUI” or the “Company”) (NYSE:SUI) securities during the period of February 28, 2019, to September 24, 2024, inclusive (“the Class Period”). Investors have until February 10, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Applied Therapeutics
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT) securities during the period from January 3, 2024 through and including December 2, 2024 (“the Class Period”). Investors have until February 18, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Kyverna Therapeutics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Kyver-na Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ:KYTX) securities during the period of February 4, 2024, to December 9, 2024, inclusive (“the Class Period”). Investors have until February 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Marqeta, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQ:MQ) securities during the period of August 7, 2024, to November 4, 2024, inclusive (“the Class Period”). Investors have until February 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name DMC Global Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Colorado on behalf of those who acquired DMC Global Inc. (“DMC Global” or the “Company”) (NASDAQ:BOOM) securities during the period of May 5, 2024, to November 4, 2024, inclusive (“the Class Period”). Investors have until February 4, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name ASP Isotopes Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired ASP Isotopes Inc. (“ASP” or the “Company”) (NASDAQ:ASPI) securities during the period of October 30, 2024, to November 26, 2024, inclusive (“the Class Period”). Investors have until February 3, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Five9, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Five9, Inc. (“Five9” or the “Company”) (NASDAQ:FIVN) securities during the period of June 4, 2024 to August 8, 2024 , inclusive (“the Class Period”). Investors have until February 3, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name ASML Holding N.V.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired ASML Holding N.V. (“ASML” or the “Company”) (NASDAQ: ASML) securities during the period of January 24, 2024 to October 15, 2024, inclusive (“the Class Period”). Investors have until January 13, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Visa Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northen District of California on behalf of those who acquired Visa Inc. (“Visa” or the “Company”) (NYSE: V) securities during the period of November 16, 2023 to September 23, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Wolfspeed, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of New York on behalf of those who acquired Wolfspeed, Inc. (“Wolfspeed” or the “Company”) (NYSE: WOLF) securities during the period of August 16, 2023 to November 6, 202024, inclusive (“the Class Period”). Investors have until January 17, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Dentsply Sirona Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Dentsply Sirona Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) securities during the period from November 1, 2022 through and including November 6, 2024 (“the Class Period”). Investors have until January 27, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Symbotic Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ:SYM) securities during the period of February 8, 2024, to November 26, 2024, inclusive (“the Class Period”). Investors have until February 3, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Rentokil Initial plc
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Tennessee on behalf of those who acquired Rentokil Initial plc (“Rentokil” or the “Company”) (NYSE: RTO) American Depository Shares (“ADSs”) during the period from December 1, 2023 to September 10, 2024, inclusive (“the Class Period”). Investors have until January 27, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Chipotle Mexican Grill, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired Chipotle Mexican Grill, Inc (“Chipotle” or the “Company”) (NYSE:CMG) securities during the period of February 8, 2024 to October 29, 2024, inclusive (“the Class Period”). Investors have until January 10, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name TMC the metals company Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired TMC the metals company Inc. (“TMC” or the “Company”) (NASDAQ:TMC) securities during the period of May 12, 2023, to March 25, 2024, inclusive (“the Class Period”). Investors have until January 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Celsius Holdings, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Florida on behalf of those who acquired Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQ:CELH) securities during the period of February 29, 2024, to September 4, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Match Group, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired Match Group, Inc. (“Match Group” or the “Company”) (NASDAQ:MTCH) securities during the period of May 2, 2023, to November 6, 2024, inclusive (“the Class Period”). Investors have until January 24, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Humacyte, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the North Carolina Middle District on behalf of those who acquired Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQ: HUMA) securities during the period of May 10, 2024 to October 17, 2024, inclusive (“the Class Period”). Investors have until January 17, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Quanterix Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX). The investigation concerns whether Quanterix and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Zeta Global Holding Corp.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSE:ZETA) securities during the period of February 27, 2024, to November 13, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Hasbro, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Hasbro, Inc. (“Hasbro” or the “Company”) (NASDAQ:HAS) securities during the period of February 7, 2022 to October 25, 2023, inclusive (“the Class Period”). Investors have until January 13, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name The Toronto-Dominion Bank
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired The Toronto-Dominion Bank ("TD Bank” or the “Company”) (NYSE: TD) securities during the period of February 29, 2024 and October 9, 2024, inclusive (“the Class Period”). Investors have until December 23, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Huntington Ingalls Industries, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that it is investigating potential claims against Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or the “Company”) (NYSE: HII). The investigation concerns whether Huntington Ingalls and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name MediaAlpha, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against MediaAlpha, Inc. (“MediaAlpha” or the “Company”) (NYSE: MAX) The investigation concerns whether MediaAlpha and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Xerox Holdings Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for Southern District of New York on behalf of those who acquired Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQ:XRX) securities during the period of January 25, 2024 to October 28, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Flux Power Holdings, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Nevada on behalf of those who acquired Flux Power Holdings, Inc. (“Flux Power” or the “Company”) (NASDAQ: FLUX) securities during the period of November 11, 2022 to September 30, 2024, inclusive (“the Class Period”). Investors have until December 31, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name PACS Group, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired PACS Group, Inc. (“PACS” or the “Company”) (NYSE:PACS): (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s April 11, 2024 initial public offering (“IPO” or the “Offering”); and/or (b) securities during the period of April 8, 2024, to November 5, 2024, inclusive (“the Class Period”). Investors have until January 13, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Evolv Technologies Holdings, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”) (NASDAQ: EVLV) securities during the period of August 19, 2022 to October 30, 2024, inclusive (“the Class Period”). Investors have until December 31, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name ADMA Biologics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ: ADMA). The investigation concerns whether ADMA and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Aviat Networks, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Aviat Networks, Inc. (“Aviat” or the “Company”) (NASDAQ: AVNW). The investigation concerns whether Aviat and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Napco Security Technologies, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC). The investigation concerns whether Napco and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Migom Global Corp.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Migom Global Corp. ("Migom” or the “Company”) (OTHER: GRTS) securities during the period of December 6, 2019 and August 25, 2022, inclusive (“the Class Period”). Investors have until December 24, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Mynaric AG
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Mynaric AG (“Mynaric” or the “Company”) (NASDAQ: MYNA) securities during the period of June 20, 2024 to October 7, 2024, inclusive (“the Class Period”). Investors have until December 30, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Franklin Resources, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Franklin Resources, Inc. (“Franklin” or the “Company”) (NASDAQ: BEN). The investigation concerns whether Franklin and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Cardlytics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX). The investigation concerns whether Cardlytics and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Medpace Holdings, Inc
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP). The investigation concerns whether Medpace and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name CFTC v. Shak,
  No. 14-cv-01632 (D.D.C.).  
• Type Commodities
• Status Pending
• Representation of a defendant in a case brought by the CFTC under the Commodity Exchange Act’s newest provisions for violations of an administrative order in the gold futures market.

• Name In re Cattle Antitrust Litigation,
  No. 19-cv-1222 (D. Minn.).
• Type Commodities
• Status Pending
• Court-appointed executive committee member and class counsel representing cattle producers and cattle futures traders in a lawsuit alleging that the “Big 4” meatpacking firms conspired to suppress prices for fed cattle and manipulated live cattle futures traded on the Chicago Mercantile Exchange.

• Name Dufoe v. DraftKings Inc., et al, 23-cv-10524 (D.Mass.). 
• Type Securities
• Status Pending
• Lead counsel to a class of investors that purchased non-fungible tokens (NFTs) from DraftKings Inc., which operates as a daily fantasy sports contest and sports betting company. The case alleges that DraftKings sold unregistered securities and ensured that money stayed on DraftKings’ private and exclusively controlled marketplace, propping up the market for an overall valuation of DraftKings’ NFTs and significantly harming investors.  

• Name Macovski v. Groupon Inc.,
  No. 20-cv-2581 (N.D. Ill.).
• Type Securities
• Status Settled
• We acted as co-lead counsel in this securities class action alleging that the company made materially false and misleading statements and failed to disclose to investors its financial health before ending its sale of physical goods and announcing the departure of two top executives. The case resulted in a $13.5 million settlement that has received final approval.

• Name In re JPMorgan Treasury Futures Spoofing Litigation, 
  No. 20-cv-03515 (S.D.N.Y.).
• Type Antitrust, Commodities
• Status Settled
• Lead counsel in an antitrust case alleging that J.P. Morgan unlawfully and intentionally manipulated U.S. Treasury Futures or Options on U.S. Treasury Futures traded on United States-based exchanges, including but not limited to the Chicago Mercantile Exchange, including its subsidiary the Chicago Board of Trade, during the Class Period in violation of the Commodity Exchange Act, 7 U.S.C. §§ 1, et seq. (the “CEA”) and the common law.  The case resulted in a settlement of $15.7 million.

• Name Doyle v. Reata Pharmaceuticals, Inc.,
  No. 21-cv-00987 (E.D. Tex.).
• Type Securities
• Status Settled
• We are representing Wespath, the General Board of Pension and Health Benefits of the United Methodist Church, in this securities class action alleging that Reata Pharmaceuticals made false and/or misleading statements — including in connection with its secondary public stock offerings — concerning, inter alia, the FDA guidance regarding the design of the clinical trial (CARDINAL) for Reata’s drug candidate, bardoxolone methyl. When the FDA revealed serious concerns it had previously raised to Reata, the share price declined materially.  The case has resulted in a settlement of $45 million.

• Name CFTC Whistleblower Award,
  No. 21-WB-07
• Type Antitrust, CFTC Whistleblower, Commodities, False Claims Act, Whistleblower
• Status Settled
• KM represented the whistleblower who received nearly $200 million, the largest CFTC whistleblower award ever and the second largest whistleblower award arising under the Dodd-Frank and IRS whistleblower programs. The information the whistleblower provided catalyzed investigations by the Commodity Futures Trading Commission (CFTC), a U.S. federal regulator, and a foreign regulator into the manipulation of crucial financial benchmarks used by global banks as the basis for the pricing of fixed income securities and derivative products.  The CFTC initially rejected the whistleblower’s award application, but KM's advocacy resulted in a successful appeal for the client.

• Name Kokareva v. Bristow Group Inc., 
  No. 19-cv-00509 (S.D. Tex.).
• Type Securities
• Status Settled
• We acted as co-lead counsel in this securities class action alleging that an aviation services provider, focused on the oil and gas sector, made materially false and misleading statements about its internal controls relating to covenants in the company’s secured financing agreements. The case resulted in a $6.25 million settlement that has received final approval.

• Name In re Foreign Exchange Benchmark Rates Antitrust Litigation, 
  No. 13-cv-07789 (S.D.N.Y.).
• Type Antitrust, Commodities
• Status Settled
• Special fiduciary representation for the exchange-based class for a putative class of participants who traded futures and options in the FX market. The case has already resulted in partial settlements of more than $2.3 billion.

• Name In re Resonant Inc. Securities Litigation,
  No. 15-cv-01970 (C.D. Cal.).
• Type Securities
• Status Settled
• In re Resonant Inc. Securities Litigation, No. 15-cv-01970 (C.D. Cal. 2017).  Co-lead counsel.  $2.75 million settlement.

• Name Rothstein v. GMAC Mortgage LLC,
  No. 12-cv-03412 (S.D.N.Y.).
• Type Consumer Fraud
• Status Settled
• Rothstein v. GMAC Mortgage LLC, No. 12-cv-03412 (S.D.N.Y.).  Lead counsel.  $13 million settlement against GMAC Mortgage LLC in In re Residential Capital, LLC, No. 12-12020 (Bankr. S.D.N.Y. 2016).

• Name In re Hi-Crush Partners L.P. Securities Litigation,
  No. 12-cv-08557 (S.D.N.Y.).  
• Type Securities
• Status Settled
• In re Hi-Crush Partners L.P. Securities Litigation, No. 12-cv-08557 (S.D.N.Y. 2015).  Lead counsel.  $3.8 million settlement while class certification was pending.

• Name In re LIBOR-Based Financial Instruments Antitrust Litigation,
  No. 11-md-02262 (S.D.N.Y.). 
• Type Antitrust, Commodities
• Status Settled
• KM filed the first LIBOR manipulation lawsuit on behalf of investors and currently serves as court-appointed co-lead counsel for the exchange-based class alleging the fixing of prices of a benchmark interest rate. The case resulted in settlements totaling $190.45 million, which combined represent the largest recovery in a “futures-only” commodities class action litigation.

• Name In re Citigroup Inc Securities Litigation, 
  No. 07-cv-09901 (S.D.N.Y.).  
• Type Securities, Structured Finance
• Status Settled
• Lead counsel for individual investor lead plaintiffs in this securities fraud class action relating to Citigroup’s exposure to losses associated with its creation or sponsorship of numerous collateralized debt obligations (“CDOs”).  This case resulted in a settlement of $590 million for the class.  The settlement was, at the time, the largest CDO-related settlement ever, as well as the largest settlement of a fraud-only action.  A later filed SEC complaint concerning similar allegations settled for a small fraction of the class action settlement amount.